Predictive Oncology Inc. (POAI) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Track Predictive Oncology Inc. (POAI) stock performance with short-term forecasts for 2025 and long-term POAI price prediction till 2050. Review historical trends, get analyst Buy/Sell/Hold ratings, and stay updated with the latest Predictive Oncology Inc. headlines.
1 Month Prediction
$1.39 [-17.80%]
3 Month Prediction
$1.00 [-40.83%]
6 Month Prediction
$1.00 [-40.83%]
1 Year Prediction
$1.00 [-40.83%]
3 Year Prediction
$1.00 [-40.83%]
5 Year Prediction
$1.00 [-40.83%]
About Predictive Oncology Inc.
Predictive Oncology Inc., is a biotechnology company that uses artificial intelligence (AI) and machine learning (ML) to improve drug discovery and development for cancer treatment. The company utilizes its AI platform, PEDAL, to predict whether a tumor sample will respond to specific drug compounds. In fact, Its platform has been scientifically validated to predict with 92% accuracy.
The company has a biobank of over 150,000 assay-capable heterogeneous human tumor samples, which supports its research and improves its predictive capabilities.
The company was founded in 2002, and is headquartered in Pittsburgh, Pennsylvania.
Predictive Oncology Inc. (POAI) Historical Performance
IPO Date
Predictive Oncology Inc. (NASDAQ:POAI) went public on 23 April, 2002.
Change
Since inception, POAI has decreased by 100.00%. In the last 5 years, POAI has fallen from $29.60 to $1.69, a massive -94.29% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $32.80 and a low of $0.72.
52 Week Range
$0.55
$3.06
The current price $1.69 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
POAI Stock Price History
Based on POAI stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the POAI stock has fallen from $13.72 - $49.0 to $1.39 - $1.69, which is down -98.52%. Currently, the stock follows downward trend.
Here, we have calculated stock range of POAI, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $13.72 - $49.0 | $27.13 | -73.66 | 1 Year Change |
| 2021 | $19.04 - $29.4 | $23.47 | -77.21 | 2 Year Change |
| 2022 | $5.46 - $19.54 | $10.47 | -89.83 | 3 Year Change |
| 2023 | $2.84 - $10.6 | $4.96 | -95.18 | 4 Year Change |
| 2024 | $0.72 - $3.08 | $1.48 | -98.56 | 5 Year Change |
| 2025 | $1.39 - $1.69 | $1.52 | -98.52 | 6 Year Change |
POAI Price Performance
6-Month Performance
POAI stock jumped by 135.70% in the last six months.
1-Year Performance
The stock has trended upwards by 19.86% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 88.31%.
5-Year Performance
In the last 5 years, the stock has gone down by 94.29%.
According to Predictive Oncology Inc.'s historical data, below graph gives us the exact picture of how the POAI stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
71.95% ↓
2021
30.05% ↑
2022
67.75% ↓
2023
46.42% ↓
2024
75.08% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Predictive Oncology Inc. (POAI) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $345.69 T (Q3)
Revenue for Q3 ending 30th September, 2024 increased 24.03% compared to Q2 ending 30th June, 2024.
Annual Revenue: $1.38 M (1Y)
Revenue for trailing 12 months decreased 22.53% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone up from $1.25 million to $1.38 million, a 10.13% change.
Market Capitalization
Predictive Oncology Inc. has a market capitalization of $12.18M, which places POAI in the nano-cap category.
Fundamental Analysis
EPS: $-0.48 (Q3), $-3.48 (1Y)
EPS decreased 29.41% since last quarter, and decreased 50.14% since last year.
Net Income: $-3.09 M (Q3), $-13.98 M (1Y)
Net Income decreased 2.72% since last quarter, and decreased 45.67% since last year.
Free Cash Flow: $-2.28 M (Q3), $-13.49 M (1Y)
Free Cash Flow decreased 29.31% since last quarter, and increased 5.02% since last year.
Net Profit Margin: -895.23% (Q3), -1014.00% (1Y)
Net Profit Margin decreased 21.57% since last quarter, and decreased 29.87% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for POAI stock. These indicators help you understand Predictive Oncology Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for POAI stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $1.22 |
| SMA50 | $1.35 |
| SMA200 | $1.02 |
| RSI | 70.59 |
| Beta | 1.22 |
SMA20 < Current Price
This signals POAI stock is in short-term bullish momentum.
SMA50 < Current Price
This signals POAI stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals POAI stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for POAI stock is Bullish. Out of all indicators, 5 indicates bullish signals, 3 signals bearish trends and 1 gives neutral trends. The POAI stock forecast was last updated on 26 March, 2025.
Predictive Oncology Inc. (POAI) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to fall to $1.00 by the end of 2025, and can reach around $0.98 to $1.09 in 2026. And, the long-term forecast suggests that the stock may further drop to $0.65 - $1.27 in 2028, and $0.68 - $1.31 by 2031. So, the POAI stock shows a strong downward trend in the next several years.
Short-term POAI Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $1.39 | -17.75% |
| 2025-05 | $1.23 | -27.22% |
| 2025-06 | $1.00 | -40.83% |
| 2025-07 | $1.00 | -40.83% |
| 2025-08 | $1.00 | -40.83% |
| 2025-09 | $1.00 | -40.83% |
| 2025-10 | $1.00 | -40.83% |
| 2025-11 | $1.00 | -40.83% |
| 2025-12 | $1.00 | -40.83% |
In 2025, the POAI stock price is expected to fluctuate between $1.0 and $1.39. According to the monthly forecast, the stock could drop to $1.00 by December 2024. If compared to the POAI's current price, the stock could lose -40.83% by the end of this year.
Long-term POAI Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $0.98 | $0.86 | $1.09 | -35.5% |
| 2027 | $1.18 | $1.07 | $0.73 | -56.8% |
| 2028 | $0.65 | $1.18 | $1.27 | -24.85% |
| 2029 | $0.91 | $1.20 | $0.83 | -50.89% |
| 2030 | $0.63 | $1.05 | $0.95 | -43.79% |
| 2031 | $0.68 | $1.04 | $1.31 | -22.49% |
| 2032 | $0.86 | $0.50 | $0.95 | -43.79% |
| 2033 | $1.05 | $0.71 | $1.24 | -26.63% |
| 2034 | $1.21 | $0.95 | $0.75 | -55.62% |
| 2035 | $1.19 | $1.04 | $1.16 | -31.36% |
| 2036 | $0.88 | $1.29 | $1.05 | -37.87% |
| 2037 | $0.82 | $0.95 | $1.08 | -36.09% |
| 2038 | $0.69 | $0.98 | $1.16 | -31.36% |
| 2039 | $0.90 | $1.09 | $0.92 | -45.56% |
| 2040 | $1.33 | $0.63 | $0.66 | -60.95% |
| 2041 | $1.36 | $1.11 | $1.05 | -37.87% |
| 2042 | $1.06 | $1.07 | $0.93 | -44.97% |
| 2043 | $1.05 | $1.30 | $1.00 | -40.83% |
| 2044 | $0.72 | $0.84 | $0.93 | -44.97% |
| 2045 | $1.09 | $0.94 | $0.76 | -55.03% |
| 2046 | $1.27 | $0.84 | $0.82 | -51.48% |
| 2047 | $1.18 | $0.63 | $0.91 | -46.15% |
| 2048 | $0.94 | $1.00 | $1.48 | -12.43% |
| 2049 | $0.96 | $1.06 | $0.69 | -59.17% |
| 2050 | $1.68 | $0.65 | $1.00 | -40.83% |
| 2051 | $0.69 | $1.09 | $1.14 | -32.54% |
Predictive Oncology Inc. (POAI) Stock Price Prediction & Forecast 2025
At the start of 2025, the POAI stock was at $1.47. Today, it is trading at $1.69, which is 14.97% increase from price at the beginning of the year. By the end of this year, you can expect the stock to fall to $1.00 by December 2025 with a -40.83% change.
Predictive Oncology Inc. (POAI) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the POAI stock. During this period, the POAI's price is forecasted to shift from $0.98 to $0.95, which is -3.06% loss.
In 2026, the stock would possibly open at $0.98, descends to $0.86 by mid-year, and wraps up at $1.09, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $0.63, drop to $1.05 by mid-year, and finish at $0.95, which is -43.49% change from current price.
Predictive Oncology Inc. (POAI) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $0.68 to $0.66, which is down -22.43%
In 2031, we can expect POAI to fluctuate between $0.68 and $1.31, a shift indicating a -22.43% loss by year-end compared to current price. And Until 2040, POAI can likely vary from $0.66 to $1.33. By the end of 2040, the stock could record a -60.85% fall from today's stock price.
Predictive Oncology Inc. (POAI) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the POAI stock can see an a downturn from $1.36 to $1.00 in this period. In 2041, the stock can experience a low of $1.11 by mid-year, closing the year at $1.05. This results in a -34.46% decrease from today.
Moving towards the end of 2050, POAI is projected to open the year at $1.68. The stock may dip to $0.65 during mid-year and finish the year at $1.00. Compared to the stock's current price, this translates to an overall loss of -40.92% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
POAI Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| STSS | Sharps Technology, Inc. | - | $0.04 | 30.33% ▲ | $12688.0 ▲ |
| GCTK | GlucoTrack, Inc. | - | $0.25 | -29.64% ▼ | $24597.08 ▲ |
| ISRG | Intuitive Surgical, Inc. | - | $518.26 | -9.58% ▼ | $103.01 ▲ |
Last updated Mar 26 at 11:26 AM
POAI : Buy, Sell Or Hold?
Analyst Ratings
No analyst ratings available for this stock.
Expert Analysis
According to POAI short-term and long-term forecast, Predictive Oncology Inc. shares are projected to go down by 40.83%, and reach a value of $1.00 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 64.28571428571429, which signals Greed. Also, POAI has recorded 7/30 green days, which reflects a 31.818181818181817% positivity rate with a price volatility of 0.12%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that POAI stock is undervalued. So, Based on POAI prediction and analysis, it may be the best time to hold POAI stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "POAI” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.